Researchers Identified Tumor Immune Suppression Mechanism
A study published September 3, 2026, revealed how cancer cells neutralize immune system attacks.
Updated on Sept. 19, 2026 in Cancer
Live Poll
Do you believe taking antioxidant supplements is generally beneficial for your long-term health?
Researchers from the University of Cambridge and Oregon Health & Science University discovered that tumors release the antioxidant protein Peroxiredoxin 1 (PRDX1) to disable T cells. Published on September 3, 2026, these findings demonstrate how tumors deplete the reactive oxygen species required to trigger an immune response.
Why it matters
Understanding this mechanism helps explain why some cancers evade the immune system and suggests that targeting PRDX1 could improve the efficacy of existing cancer immunotherapies in human patients.
Researchers used CRISPR gene-editing to create mouse cancer cells unable to produce PRDX1, confirming the protein's role in clearing reactive oxygen species. The study verified PRDX1 presence in human cancer cell lines and tumor fluid.
The players
University of Cambridge
This is a public collegiate research university in England that maintains a global reputation for high-impact scientific and medical research.
Oregon Health & Science University
Located in Portland, this university is a major center for biomedical research and provides advanced clinical care and education.
The details
By releasing PRDX1, tumors scrub their environment of reactive oxygen species, which are essential for T cells to detect and destroy malignant cells. Removing this protein, as demonstrated in mouse models, allows the immune system to regain its ability to target and effectively fight tumor growth.
Timeline
September 3, 2026: The study was published in the journal Science.
The Big Picture
This study shifts the paradigm of cancer research by identifying a metabolic barrier that limits the efficacy of current immunotherapies. By addressing this mechanism, the work follows a pattern established by the ongoing development of checkpoint inhibitor immunotherapies.
While these findings are limited to mouse models, the discovery offers a potential new target for future immunotherapies that could help patients who do not respond to current treatments. It highlights the importance of continued research into metabolic pathways that tumors use to hide from the immune system.
The takeaway
This discovery highlights how tumors actively manipulate their environment to shield themselves from immune destruction. Clinicians and researchers may use this insight to explore prooxidant therapies designed to re-sensitize cancer cells to the body's natural defense systems.
Further reading
Learn more about the latest developments in Cancer research and treatments.
Source note: This article includes information reported by SciTechDaily.
Live Poll
Do you believe taking antioxidant supplements is generally beneficial for your long-term health?
